The NextGen BRCA Somatic Mutation Analysis test identifies acquired BRCA1 and BRCA2 mutations present in tumour cells, which can influence treatment response, especially to targeted therapies like PARP inhibitors. Metropolis Healthcare performs this test using advanced next-generation sequencing to ensure highly accurate detection of somatic genetic changes. Understanding somatic BRCA mutations helps clinicians personalize cancer treatment and improve outcomes. This test is crucial for patients with cancers where tumour genomic profiling guides therapy decisions.
Price:
Rs. 22,000.00
Sample Type: Slide,Tissue
Fasting Not Required
Notes: B0106
Frequently Asked Questions (FAQ's):
What does the NextGen BRCA Somatic Mutation Analysis include at Metropolis Healthcare?
It detects tumour-specific BRCA mutations using next-generation sequencing for treatment-guided insights.
How does Metropolis Healthcare perform this somatic mutation test?
Metropolis Healthcare uses high-precision NGS technology and validated workflows for accurate mutation profiling.
Who should take this somatic BRCA test at Metropolis Healthcare?
Patients diagnosed with cancers where BRCA status influences targeted therapy may require this test.
Do I need special preparation before giving my sample at Metropolis Healthcare?
Preparation depends on sample type and is usually guided by your treating clinician.
How soon can I get results from Metropolis Healthcare?
Results are typically available within the turnaround time required for comprehensive tumour sequencing.
Is the test reliable at Metropolis Healthcare?
Yes, Metropolis Healthcare ensures accuracy through strict quality controls and advanced sequencing standards.
How can this test help my doctor at Metropolis Healthcare?
It supports personalised treatment selection and helps determine eligibility for targeted cancer therapies.
Do I need a prescription for this test at Metropolis Healthcare?
A prescription and oncologist guidance are recommended for correct interpretation and clinical use.